Lauren Hale's perimenopause claims need more context
Quick answer
Perimenopause is the transitional period before menopause when estrogen levels fluctuate and decline, typically lasting 4-8 years. Common symptoms include hot flashes, irregular periods, and mood changes, though many symptoms overlap with other midlife health conditions requiring proper medical evaluation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Lauren Hale's Instagram video lists common symptoms women experience in their 40s and asks if they're perimenopause-related. She mentions memory issues, anxiety, weight gain, and suggests there are "more than 40 symptoms" of perimenopause.
The video doesn't make specific medical claims about treatments. Instead, it focuses on symptom recognition and community building around the perimenopause experience.
While categorized under TRT content, Hale's post doesn't actually discuss testosterone therapy or hormone treatments directly.
Are these symptoms actually linked to perimenopause?
Yes, the symptoms Hale mentions are documented perimenopause symptoms, though they're not exclusive to hormonal changes. The Study of Women's Health Across the Nation (SWAN) followed 3,302 women for over 20 years and found memory complaints increased during perimenopause.
Anxiety rates climb during perimenopause according to research by Bromberger et al. (Menopause, 2013), which found a 30% increase in anxiety symptoms during the transition.
Weight gain averaging 1.5 pounds per year is common during perimenopause, per the Melbourne Women's Midlife Health Project. However, this can overlap with age-related metabolic changes that aren't hormone-driven.
What about the "40 symptoms" claim?
Medical literature doesn't support a specific count of 40 perimenopause symptoms. The claim appears to come from patient advocacy websites rather than clinical research.
The Menopause Society recognizes about 15-20 well-documented symptoms including hot flashes, sleep disturbances, mood changes, and irregular periods.
Lists claiming 40+ symptoms often include vague complaints like "brittle nails" or "electric shocks" that lack strong research backing. This kind of symptom inflation can lead women to attribute normal aging changes to hormones unnecessarily.
What's missing from this discussion?
Hale's video lacks important context about symptom overlap. Many issues she mentions can stem from stress, sleep deprivation, thyroid problems, or depression rather than declining estrogen.
The video also doesn't mention that perimenopause typically begins in the mid-40s, making 42 relatively early for significant symptoms.
Without discussing differential diagnosis, content like this can encourage self-diagnosis when medical evaluation would be more appropriate. Thyroid disorders affect 20% of women over 40 and can mimic perimenopause symptoms exactly.
Should women be concerned about these symptoms?
Women experiencing these symptoms shouldn't ignore them, but they shouldn't assume they're hormone-related either. A healthcare provider can distinguish between perimenopause and other conditions through history and lab work.
FSH levels above 25 IU/L with irregular periods suggest perimenopause, but symptoms alone aren't diagnostic.
The real value in Hale's content is reducing isolation around midlife health changes. However, symptom awareness should lead to medical consultation, not self-diagnosis or unguided hormone experimentation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Lauren Hale's perimenopause claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Lauren Hale's perimenopause claims need more context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Perimenopause is the transitional period before menopause when estrogen levels fluctuate and decline, typically lasting 4-8 years.
FormBlends verdict
Perimenopause is the transitional period before menopause when estrogen levels fluctuate and decline, typically lasting 4-8 years. Common symptoms include hot flashes, irregular periods, and mood changes, though many symptoms overlap with other midlife health conditions requiring proper medical evaluation.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Perimenopause is the transitional period before menopause when estrogen levels fluctuate and decline, typically lasting 4-8 years. Common symptoms include hot flashes, irregular periods, and mood changes, though many symptoms overlap with other midlife health conditions requiring proper medical evaluation.
- The SWAN study documented memory complaints and anxiety increases during perimenopause in over 3,000 women
- Medical literature recognizes about 15-20 validated perimenopause symptoms, not 40+
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The SWAN study documented memory complaints and anxiety increases during perimenopause in over 3,000 women
- Medical literature recognizes about 15-20 validated perimenopause symptoms, not 40+
- Weight gain during perimenopause averages 1.5 pounds annually but overlaps with age-related metabolic changes
- Thyroid disorders affect 20% of women over 40 and can perfectly mimic perimenopause symptoms
- FSH levels above 25 IU/L with irregular periods suggest perimenopause, but symptoms alone aren't diagnostic
- Symptom awareness is valuable but should lead to medical evaluation, not self-diagnosis
- Perimenopause typically begins mid-40s, making significant symptoms at 42 relatively early
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Lauren Hale · Instagram creator
210.4K views on this video
At 42, I started experiencing changes in my body that didn’t seem normal, but I also didn’t know what was going on. 🫣Was I just getting older and forgetting names, places and people I should easily
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Lauren Hale, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.